Financials

Company Profile

Scorpius Holdings, Inc. is not engaged in any business activities. The Company was previously a contract development and manufacturing organization.

Employees

Sector

Date	Price	Change	Volume
26-06-24	$0.005600	+366.67%	1,038
26-06-23	$0.001200	-45.45%	30,615

Delayed Quote OTC Markets

Market Closed - OTC Markets Other stock markets 11:53:14 2026-06-24 am EDT			5-day change	1st Jan Change
0.005600 ^USD	+366.67%		+409.09%	+2,700.00%

Apr. 24	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
Apr. 08	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI

Apr. 24	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
Apr. 08	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI
Mar. 10	Scorpius Holdings, Inc. announced that it has received $0.031175 million in funding	CI
Feb. 25	Scorpius Holdings, Inc. announced that it has received $0.219544 million in funding	CI
Feb. 17	Scorpius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Feb. 11	Scorpius Holdings, Inc. announced that it has received $0.030427 million in funding	CI
Jan. 12	Scorpius Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
Dec. 15	Scorpius Holdings, Inc. announced that it has received $0.044374 million in funding	CI
Dec. 10	Velocity Bioworks, Inc. acquired All of Personal Property and Assets of Scorpius Holdings, Inc. for $16.3 million.	CI
Dec. 02	Scorpius Holdings, Inc. Announces Issuance of Multiple Non-Convertible Promissory Notes with Customary Terms	CI
Nov. 30	Scorpius Holdings, Inc. announced that it has received $0.1541 million in funding	CI
Nov. 25	Scorpius Holdings, Inc. announced that it has received $0.724523 million in funding	CI
Nov. 24	Scorpius Holdings, Inc. announced that it has received $0.03795 million in funding	CI

23-05-01	Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy	MT
23-04-03	Maxim Downgrades NightHawk Biosciences to Hold From Buy	MT
22-03-18	B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating	MT
22-03-15	Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating	MT
22-01-24	B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating	MT

Jan. 12	Scorpius : Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)	PU
24-11-14	Scorpius : Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability Form 8 K	PU
24-10-22	Scorpius Holdings Announces Partnership with U.S. Biotech Company	AQ
24-10-02	Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats	AQ
24-09-30	Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities	AQ

Manager	Title	Age	Since
Jeff Wolf CEO	Chief Executive Officer	63	2010-03-31
Joe Payne COO	Chief Operating Officer	-	-
David Waldman IRC	Investor Relations Contact	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
24-05-15	Jeff Wolf	Free	Chief Executive Officer	5,000,000	13.8766%
24-05-15	Seed-One Ventures LLC	Other	Company	0	0%
24-05-15	Orion Holdings LLC	Other	Company	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCORPIUS HOLDINGS, INC.	+366.67%	+409.09%	-87.19%	-100.00%	342K
EINRIDE AB	+17.31%	-9.42%	-	-	1.07B
CENTIEL AG	-9.46%	-6.81%	+375.19%	-61.51%	773M
CHURCHILL CAPITAL CORP XI	+11.41%	+34.50%	-	-	772M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.20%	-0.50%	-	-	640M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	+0.59%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	-0.15%	-0.25%	-	-	592M
CHURCHILL CAPITAL CORP XII	+0.48%	+3.88%	-	-	586M
KEYSTONE ACQUISITION CORP.	-0.10%	0.00%	-	-	580M
Average	+42.87%	+2.44%	+144.00%	-80.75%	623.5M
Weighted average by Cap.	+3.57%	+2.40%	+374.98%	-61.52%